Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 3.391
Filter
1.
Rev. cuba. med. trop ; 73(2): e609, 2021. graf
Article in English | LILACS, CUMED | ID: biblio-1347498

ABSTRACT

Coleopteran insects can produce toxic substances containing multiple components which have so far not been properly described. To report an unusual case of intoxication by excretion from Calosoma alternans Fabricius 1792 (Coleoptera: Carabidae) in a Venezuelan patient from a periurban neighborhood near the mesothermal raining forest. The toxic activity caused a clinical status characterized by digestive symptoms such as nausea, vomiting, epigastralgia, an increase in bowel movements and probable kidney inflammation with intense pain in both lumbar regions, which did not correspond to the classic dermal damage. In conclusion, a unique case is presented of intoxication by a coleopteran species, with a clinical description not previously reported(AU)


Los insectos coleópteros pueden producir sustancias tóxicas que contienen numerosos componentes que aún no han sido descritos adecuadamente. Presentar un caso inusual de intoxicación por excreciones de Calosoma alternans Fabricius 1792 (Coleoptera: Carabidae) en un paciente venezolano residente en un barrio periurbano cercano a la selva tropical mesotérmica. La actividad tóxica provocó un cuadro clínico caracterizado por síntomas digestivos como náuseas, vómitos, epigastralgia, aumento del número de deposiciones y probablemente inflamación renal, con dolor intenso en ambas regiones lumbares, lo que no se corresponde con el daño dérmico clásico. En resumen, se presenta un caso singular de intoxicación provocada por una especie de coleóptero, con una descripción clínica no reportada anteriormente(AU)


Subject(s)
Humans , Male , Signs and Symptoms , Coleoptera , Insecta , Poisoning , Venezuela , Vomiting , Toxic Substances
2.
Säo Paulo med. j ; 139(2): 147-155, Mar.-Apr. 2021. tab
Article in English | LILACS | ID: biblio-1290231

ABSTRACT

ABSTRACT BACKGROUND: The Health-Related Quality of Life Questionnaire for Nausea and Vomiting of Pregnancy (NVPQOL) is a validated questionnaire assessing quality of life among pregnant women with nausea and vomiting. OBJECTIVE: To translate, cross-culturally adapt and evaluate the reliability of the NVPQOL. DESIGN AND SETTING: Observational cross-sectional study developed in a public university in Brazil. METHODS: The translation, synthesis of translations, back-translation, expert committee, pre-testing and validation were carried out, resulting in a Portuguese-language version. The internal consistency, intra-rater and test-retest reliability and correlation between the total score of the Portuguese-language version of the NVPQOL and the domains of the World Health Organization Quality of Life-bref questionnaire were considered in the data analysis. RESULTS: The instrument went through the process with testing on 104 pregnant women. Strong internal consistency (Cronbach's α: 0.95), strong intra-rater and test-retest reliability (P < 0.0; intraclass correlation coefficient: 0.89; confidence interval: 0.791-0.945) and strong correlation between the total score of the Portuguese-language version of the NVPQOL and the physical health domain of the World Health Organization Quality of Life-bref questionnaire (P < 0.01; R = −0.8) were observed. CONCLUSION: The NVPQOL was translated, cross-culturally adapted and validated for the Portuguese language with satisfactory psychometric properties for assessing quality of life, especially in relation to physical health, among pregnant women with symptoms of nausea and vomiting in the first trimester of pregnancy.


Subject(s)
Humans , Female , Pregnancy , Quality of Life , Cross-Cultural Comparison , Psychometrics , Translations , Vomiting , Brazil , Cross-Sectional Studies , Surveys and Questionnaires , Reproducibility of Results , Nausea
3.
Med. U.P.B ; 40(1): 77-81, 03/03/2021. Ilus
Article in Spanish | LILACS, COLNAL | ID: biblio-1177502

ABSTRACT

Los diferentes reportes de consumo de sustancias evidencian cómo el consumo de alcohol afecta diferentes órganos y sistemas; según el tiempo de presentación hay riesgos agudos y crónicos. Dentro de las complicaciones agudas gastrointestinales asociadas al consumo de alcohol está el síndrome de Boerhaave consistente en una ruptura esofágica espontánea. Es importante identificar este síndrome porque se relaciona con alta mortalidad debido a la amplia gama de signos y síntomas que produce, como vómito, disnea, taquipnea, taquicardia y dolor esternal, que pueden generar confusión con otras enfermedades como el tromboembolismo pulmonar. El objetivo de este reporte es pre-sentar el primer caso clínico en Colombia de un paciente con síndrome de Boerhaave como complicación del consumo de alcohol, ya que es importante que el personal de salud reconozca los factores de riesgo que lo desencadenan.


Numerous reports of substance use show how alcohol consumption affects different organs and systems; related risks can be acute and chronic, depending on the time of presentation. Among the acute gastrointestinal complications associated with alcohol consumption is Boerhaave syndrome, which consists of a spontaneous esophageal rupture. It is important to identify this pathology because it is associated with high mortality due to the wide range of signs and symptoms that it produces such as vomiting, dyspnea, tachypnea, tachycardia, and sternal pain, which can lead to confusion with other diseases like pulmonary thromboembolism and may therefore delay proper and timely diagnostic. The objective of this report is to present the first clinical case reported in Colombia of a patient who suffered from Boerhaave syndrome secondary to chronic alcohol consumption and to sensitize the health personnel about the importance of recognizing alcohol consumption as a risk factor for this complication.


Os diferentes relatos de uso de substâncias mostram como o consumo de álcool afeta diferentes órgãos e sistemas; dependendo da época de apresentação, existem riscos agudos e crônicos. Entre as complicações gastrointestinais agudas associadas ao con-sumo de álcool está a síndrome de Boerhaave, que consiste em uma ruptura esofágica espontânea. É importante identificar essa síndrome, pois está associada a alta mortalidade devido à ampla gama de sinais e sintomas que produz, como vômitos, dispneia, taquipneia, taquicardia e dor esternal, que podem levar à confusão com outras doenças, como tromboembolismo pulmonar. O objetivo deste relatório é apresentar o primeiro caso clínico na Colômbia de um paciente com síndrome de Boerhaave como uma complicação do consumo de álcool, pois é importante que o pessoal de saúde reconheça os fatores de risco que a desencadeiam.


Subject(s)
Humans , Alcohol Drinking , Pain , Pulmonary Embolism , Rupture , Tachycardia , Vomiting , Confusion , Ethanol
4.
São Paulo; s.n; HSPM; 2021.
Thesis in Portuguese | LILACS, ColecionaSUS, SMS-SP, HSPM-Producao, SMS-SP | ID: biblio-1348451

ABSTRACT

RESUMO Introdução: Há duas décadas, a incidência de náuseas e vômitos tem se mantido inalterada, sendo intercorrências comuns no pós-operatório. A profilaxia antiemética é benéfica, mas não deve ser realizada indiscriminadamente, pois não está isenta de efeitos deletérios. A acupuntura é um método de estimulação neural periférico. Registros de cerca de 2000 anos relatam o seu uso para tratamento de náuseas e vômitos. Objetivo: Avaliar a eficácia da acupuntura na prevenção e tratamento de náuseas e vômitos no período pós-operatório. Método: A base de dados utilizada para seleção dos trabalhos foi a PUBMED, utilizando a seguinte estratégia de busca: (nausea[title] AND vomiting[title] AND postoperative[title]) AND (acupuncture[title]). Como critérios de inclusão, foram considerados apenas os ensaios clínicos relacionados ao tema. Resultados: Após a busca, 16 ensaios clínicos foram incluídos na presente revisão. Conclusões: A acupuntura foi eficaz na prevenção de náuseas e vômitos no período pós-operatório em adultos, especialmente em mulheres. Todavia, estudos controlados e com amostras maiores ainda se mostram necessários, bem como estudos envolvendo indivíduos do sexo masculino, assim como crianças. Palavras-chave: Anestesiologia. Acupuntura. Cirurgia. Náuseas. Vômitos. Tratamento.


Subject(s)
Humans , Male , Female , Therapeutics , Vomiting , Acupuncture , Anesthesiology , Nausea
5.
Rev. gaúch. enferm ; 42(spe): e20200205, 2021. tab, graf
Article in English | LILACS, BDENF | ID: biblio-1251789

ABSTRACT

ABSTRACT Objective To identify symptoms of COVID-19 in adults in the scientific literature. Method Systematic review of studies published from December 1, 2019 to April 21, 2020 from the Scopus, Web of Science and PubMed databases, in order to answer the following research question: "What are the symptoms caused by COVID-19 in adults?" using the keywords "Symptoms", "Clinical Manifestations", "Coronavirus", "COVID-19". Results Of the total 105 references, 13 references that addressed the symptoms of COVID-19 were selected. Fever and normal or dry cough were symptoms present in all studies. Conclusion The symptoms identified in adult patients were fever, normal or dry cough, headache, pharyngalgia, dyspnea, diarrhea, myalgia, vomiting, sputum or expectoration, anxiety or chest pain, fatigue, nausea, anorexia, abdominal pain, rhinorrhea, runny nose or nasal congestion, dizziness, chills, systemic pain, mental confusion, hemoptysis, asthma, taste disorder, smell disorder, belching and tachycardia.


RESUMEN Objetivo Verificar en la literatura científica las manifestaciones sintomáticas de COVID-19 en adultos. Método Una revisión sistemática realizada en las bases de datos Scopus, Web of Science y PubMed con estudios publicados del 1 de diciembre de 2019 al 21 de abril de 2020, con el fin de responder a la pregunta orientadora: "¿Cuáles son las manifestaciones sintomáticas causada por COVID-19 en adultos?" utilizando las palabras clave: "Síntomas", "Manifestaciones clínicas", "Coronavirus", "COVID-19". Resultados Del total de 105 referencias, se seleccionaron 13 que abordaron las manifestaciones sintomáticas de COVID-19, con fiebre y tos normal o seca presente en todos los estudios. Conclusión Las manifestaciones sintomáticas identificadas en pacientes adultos fueron: fiebre, tos normal o seca, dolor de cabeza, faringalgia, disnea, diarrea, mialgia, vómitos, esputo o expectoración, angustia o dolor en el pecho, fatiga, náuseas, anorexia, dolor abdominal, rinorrea, secreción nasal o congestión nasal, mareos, escalofríos, dolor sistémico, confusión mental, hemoptisis, asma, alteración del gusto, alteración del olfato, eructos y taquicardia.


RESUMO Objetivo Verificar na literatura científica as manifestações sintomáticas da COVID-19 em pessoas adultas. Método Revisão sistemática utilizando as bases Scopus, Web of Science e PubMed com estudos publicados de 1 de dezembro de 2019 a 21 de abril de 2020, a fim de responder à questão norteadora: "Quais as manifestações sintomáticas causada pela COVID-19 em pessoas adultas?" utilizando-se as palavras-chave: "Symptoms", "Clinical Manifestations", "Coronavirus", "COVID-19". Resultados Do total de 105 referências, foram selecionadas 13 que abordaram as manifestações sintomáticas da COVID-19, estando a febre e a tosse normal ou seca presente em todos os estudos. Conclusão As manifestações sintomáticas identificadas nos pacientes adultos foram: febre, tosse normal ou seca, cefaleia, faringalgia, dispneia, diarreia, mialgia, vômito, escarro ou expectoração, angústia ou dor no peito, fadiga, náusea, anorexia, dor abdominal, rinorreia, coriza ou congestão nasal, tontura, calafrios, dor sistêmica, confusão mental, hemoptise, asma, comprometimento do paladar, comprometimento do olfato, arroto e taquicardia.


Subject(s)
Humans , Male , Female , Adult , General Symptoms , SARS-CoV-2 , COVID-19 , Asthma , Vomiting , Anorexia , Databases, Bibliographic , Cough , Ageusia , Diarrhea , Dizziness , Fatigue , Fever , Olfaction Disorders
6.
Arq. gastroenterol ; 57(4): 354-360, Oct.-Dec. 2020. tab, graf
Article in English | LILACS | ID: biblio-1142334

ABSTRACT

ABSTRACT BACKGROUND: Cancer patients may have gastrointestinal changes that influence nutritional status. OBJECTIVE: To investigate the occurrence of gastrointestinal changes resulting from outpatient chemotherapy treatment in cancer patients. METHODS: In a retrospective longitudinal study, the nutritional status and chemotherapy gastrointestinal changes (nausea, vomit, diarrhea, constipation, mucositis, dysphagia, xerostomia, inappetence, dysgeusia and heartburn) in cancer patients (n=187) were investigated in an outpatient follow-up. For the study of the parameters over time, the generalized estimating equation (GEE) method was used. Kruskal-Wallis, Mann-Whitney tests and Spearman coefficient, at a significance level of 5% were also used. RESULTS: The majority of the patients were female (63.64%) and the mean age was 57.5±12.1 years. The most frequent symptoms were nausea (18.54%); inappetence (18.31%); intestinal constipation (11.58%); diarrhea (7.98%); xerostomia (7.59%) and vomiting (7.43%). The nutritional status did not exhibit any relevant changes (P=0.7594). However, a higher prevalence of eutrophy was observed, followed by overweight; vomiting exhibited a significant difference (P=0.0211). The nausea symptom exhibited a significant difference with a higher prevalence of colorectal neoplasia when compared to breast neoplasia (P=0.0062); as well as vomiting in lung and colorectal neoplasias (P=0.0022), and dysphagia, in head and neck neoplasia, when compared to other neoplasms (P<0.001). There was a statistically significant difference between the number of medical appointments and gender (P=0.0102) and between dysphagia and gender (P<0.0001). CONCLUSION: The study findings enhance the need for signs and symptoms follow up, as well as nutritional status follow up of patients undergoing outpatient chemotherapy.


RESUMO CONTEXTO: Pacientes oncológicos podem apresentar alterações gastrointestinais que influenciam o estado nutricional. OBJETIVO: Investigar a ocorrência de alterações gastrointestinais decorrentes do tratamento ambulatorial de quimioterapia, em pacientes oncológicos. MÉTODOS: Num estudo longitudinal retrospectivo, investigou-se o estado nutricional e as alterações gastrointestinais (náuseas, vômito, diarreia, constipação, mucosite, disfagia, xerostomia, inapetência, disgeusia e pirose) de pacientes oncológicos (n=187), em acompanhamento ambulatorial de quimioterapia. Para o estudo dos parâmetros ao longo do tempo, utilizou-se o método das equações de estimação generalizadas (EEG). Também foram utilizados os testes de Kruskal-Wallis, Mann-Whitney e o coeficiente de Spearman, com nível de significância de 5%. RESULTADOS: A maioria dos pacientes era do sexo feminino (63,64%) e a média de idade foi 57,5±12,1 anos. Os sintomas mais frequentes foram náuseas (18,54%); inapetência (18,31%); constipação intestinal (11,58%); diarreia (7,98%); xerostomia (7,59%) e vômito (7,43%). O estado nutricional não apresentou alterações relevantes (P=0,7594). No entanto, observou-se maior prevalência de eutrofia, seguido do sobrepeso e o vômito apresentou diferença significativa (P=0,0211). O sintoma de náusea apresentou diferença significativa com maior prevalência na neoplasia colorretal, quando comparado à neoplasia de mama (P=0,0062); assim como o vômito nas neoplasias de pulmão e colorretal (P=0,0022). E a disfagia, na neoplasia de cabeça e pescoço, quando comparada às demais neoplasias (P<0,001). Houve diferença estatisticamente significante entre o número de consultas médicas e sexo (P=0,0102) e entre disfagia e sexo (P<0,0001). CONCLUSÃO: Os achados encontrados no estudo permitem reforçar a necessidade do acompanhamento de sinais e sintomas, bem como do estado nutricional, de pacientes em acompanhamento ambulatorial de quimioterapia.


Subject(s)
Humans , Female , Adult , Aged , Outpatients , Gastrointestinal Diseases/etiology , Neoplasms/complications , Neoplasms/drug therapy , Antineoplastic Agents/therapeutic use , Vomiting/etiology , Weight Loss , Nutritional Status , Retrospective Studies , Follow-Up Studies , Longitudinal Studies , Constipation/etiology , Diarrhea/etiology , Dyspepsia/etiology , Middle Aged , Nausea
7.
An. Fac. Cienc. Méd. (Asunción) ; 53(3): 25-32, 20201201.
Article in Spanish | LILACS | ID: biblio-1177367

ABSTRACT

Introducción: La litiasis biliar es una patología considerada como poco frecuente en la infancia; sin embargo, el 50% de los adultos jóvenes con enfermedad vesicular presentaron sus primeros síntomas a edades tempranas. Existen pocos estudios en población pediátrica con esta patología en el Paraguay. Objetivos: Determinar los síntomas más frecuentes y la presencia de factores asociados a litiasis biliar en niños y adolescentes en un hospital de referencia. Materiales y métodos: Estudio transversal, observacional, descriptivo, retrospectivo, realizado con datos secundarios de fichas clínicas de pacientes internados entre los meses de enero del 2014 y enero del 2019. Muestreo no probabilístico de casos consecutivos. Resultados: Se incluyeron 58 pacientes con diagnóstico de litiasis biliar, 3 (5,2%) en edad pre-escolar, 9 (15,5%) escolares y 46 (79,3%) adolescentes. Fueron del sexo femenino 39/58 (67,2%). En cuanto a las manifestaciones clínicas, 57 (98%) pacientes refirieron dolor abdominal, 30 (51%) presentaron vómitos y el resto en menor proporción cursaron con ictericia, coluria o hipocolia. Con respecto a la situación nutricional, 1 (1,7%) paciente presentó desnutrición y 29 (50%) pacientes sobrepeso u obesidad. En relación con la evaluación de la talla, 5 (8,6%) tenían talla baja. En 4 (6,8%) pacientes hubo antecedentes familiares de litiasis biliar. Ninguno presentó complicaciones. No se observaron casos asociados a uso de nutrición parenteral. 2 pacientes habían recibido antibiótico de amplio espectro. Conclusión: La litiasis biliar fue más frecuente en niñas y en la etapa de la adolescencia, en la mayoría fue idiopática y el dolor abdominal fue la manifestación más frecuente. Conclusión: La litiasis biliar fue más frecuente en niñas y en la etapa de la adolescencia, en la mayoría fue idiopática y el dolor abdominal fue la manifestación más frecuente.


Introduction: Gallstones are considered infrequent in childhood; however, 50% of young adults with gallbladder disease had their first symptoms during this period. There are few studies in the pediatric population about this pathology in Paraguay. Objectives: To determine the prevalent symptoms and the presence of predisposing factors in children and adolescents with gallstones at a referral hospital. Materials and methods: it is a cross-sectional, retrospective, descriptive, observational study; based on clinical records of patients hospitalized between January 2014 and January 2019, non-probabilistic sampling of consecutive cases of patients who meet the inclusion criteria. Results: 58 patients with the diagnosis of gallstones were found, of which 3 (5.2%) were preschool children, 9 (15.5%) children and 46 (79.3%) adolescents. There was a predominance of females 67.2% (39/58) over males 33% (19/58). As for clinical manifestations, 57 patients (98%) reported abdominal pain, 30 (51%) vomiting and a lesser extent coursed with jaundice, dark urine or hypocolia. Regarding the nutritional profile, 1 patient (8,6%) presented malnutrition and 29 (50%) were overweight or obese. In relation to height, 5 (8.6%) were short stature. Only 4 patients (6.8%) had a family history of gallstones. None of them had complications or were associated to parenteral nutrition. 2 patients had received broad spectrum antibiotics. Conclusion: Gallstones occurred mainly in female adolescents. In most cases was idiopathic and, abdominal pain was the most frequent symptom.


Subject(s)
Vomiting , Gallstones , Lithiasis , Overweight , Jaundice , Obesity , Population , Women , Disease , Gallbladder Diseases
8.
Arq. neuropsiquiatr ; 78(2): 121-123, Feb. 2020. graf
Article in English | LILACS | ID: biblio-1088997

ABSTRACT

ABSTRACT First described by Retzius at the end of the 19th century, the structure in the posterior medulla oblongata, then named area postrema, underwent an intense investigation into its function in the decades that followed. Findings, mainly in animal studies, have partially elucidated its role as an emetic center in the central nervous system. In the second half of the 20th century, this function was associated with reports of syndromes characterized by uncontrollable nausea and vomiting related to structural damage in the area postrema, mainly in the context of demyelinating diseases. At the beginning of the 21st century, the so-called area postrema syndrome has been consolidated as a diagnostic factor in diseases related to the spectrum of neuromyelitis optica, more than 100 years after its first description.


RESUMO Descrita pela primeira vez por Retzius no final do século XIX, a estrutura na medula oblonga posterior, então nomeada de área postrema, passou por intensa investigação quanto à sua função nas décadas seguintes. Achados sobretudo em estudos com animais elucidaram parcialmente sua função como centro emético no sistema nervoso central. Na segunda metade do século XX, tal função foi associada a relatos de síndromes caracterizadas por náuseas e vômitos incoercíveis relacionadas a lesões estruturais na área postrema, principalmente no contexto das doenças desmielinizantes. Já no início do século XXI, a então chamada síndrome da área postrema se consolida como fator diagnóstico nas doenças relacionadas ao espectro da neuromielite óptica, mais de 100 anos sua primeira descrição.


Subject(s)
Humans , Neuromyelitis Optica , Area Postrema , Syndrome , Vomiting , Nausea
9.
Rev. Soc. Bras. Med. Trop ; 53: e20200714, 2020. tab, graf
Article in English | LILACS, ColecionaSUS, SES-SP | ID: biblio-1143864

ABSTRACT

Abstract INTRODUCTION: The pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has greatly challenged public health worldwide. A growing number of studies have reported gastrointestinal (GI) symptoms. We performed a systematic review of GI symptoms associated with coronavirus disease 2019 (COVID-19) as well as of the serum levels of biomarkers related to liver function and lesion in SARS-CoV-2-infected individuals. METHODS: We surveyed relevant articles published in English, Spanish, and Portuguese up to July, 2020 in the PubMed, MEDLINE, SciELO, LILACS, and BVS databases. Moreover, we surveyed potentially important articles in journals such as the NEJM, JAMA, BMJ, Gut, and AJG. RESULTS: This systematic review included 43 studies, including 18,246 patients. Diarrhea was the most common GI symptom, affecting 11.5% of the patients, followed by nausea and vomiting (6.3%) and abdominal pain (2.3%). With regard to clinical severity, 17.5% of the patients were classified as severely ill, whereas 9.8% of them were considered to have a non-severe disease. Some studies showed increased aspartate transaminase and alanine aminotransferase levels in a portion of the 209 analyzed patients and two studies. CONCLUSIONS: Our results suggest that digestive symptoms are common in COVID-19 patients. In addition, alterations in cytolysis biomarkers could also be observed in a lesser proportion, calling attention to the possibility of hepatic involvement in SARS-CoV-2-infected individuals.


Subject(s)
Humans , Coronavirus Infections/pathology , Gastrointestinal Diseases/virology , Vomiting/virology , Abdominal Pain/virology , Diarrhea/virology , Pandemics , Nausea/virology
10.
Rev. saúde pública (Online) ; 54: 106, 2020. tab, graf
Article in English | LILACS, BBO, SES-SP | ID: biblio-1139472

ABSTRACT

ABSTRACT OBJECTIVE: To estimate the incidence and to evaluate risk factors for antineoplastic nausea and vomiting with high and moderate emetogenic chemotherapy in adult patients in the first treatment cycle. METHODS: Prospective cohort study with follow-up of 269 adults during the first cycle of antineoplastic chemotherapy. The incidence of nausea and vomiting was evaluated in the acute phase (0-24 hours), in the late phase (24 hours-5th day) and in the total phase (0-5th day). RESULTS: In total, 152 patients underwent high emetogenic chemotherapy and 117 moderate emetogenic chemotherapy. The relative frequency of nausea was higher when compared with vomiting in the acute phase (p < 0.001) and in the late phase (p < 0.001). The risk factors identified were: age group ≤ 49 years (odds ratio = 0.47; 95%CI 0.23-0.95) and 50-64 years (odds ratio = 0.45; 95%CI 0.23-0.87), tobacco use (odds ratio = 0.35; 95%CI 0.14-0.88), and high emetogenic chemotherapy (odds ratio 0.55; 95%CI 0.31-0.95). CONCLUSION: The incidence of nausea was higher than that of vomiting, and adverse effects were more frequent in the late phase. The results suggest the risk factors for chemotherapy-induced nausea and vomiting are tobacco, age (young adults), and high emetogenic chemotherapy.


RESUMO OBJETIVO: Estimar a incidência e avaliar os fatores de risco para náuseas e vômitos induzidos por antineoplásicos com alto e moderado potencial emético em pacientes adultos, no primeiro ciclo de tratamento. MÉTODOS: Estudo de coorte prospectiva, com 269 adultos acompanhados durante o primeiro ciclo de quimioterapia antineoplásica. A incidência de náuseas e vômitos foi avaliada na fase aguda (0-24 horas), na fase tardia (24 horas-5° dia) e na fase total (0-5° dia). RESULTADOS: 152 pacientes foram submetidos a quimioterápico com alto potencial emético e 117 a moderado potencial emético. A frequência relativa de náuseas foi maior quando comparada à de vômitos na fase aguda (p < 0,001) e na fase tardia (p < 0,001). Os fatores de risco identificados foram: faixa etária ≤ 49 anos (odds ratio = 0,47; IC95% 0,23-0,95) e 50-64 anos (odds ratio = 0,45; IC95% 0,23-0,87), uso de tabaco (odds ratio = 0,35; IC95% 0,14-0,88) e alto potencial emético dos quimioterápicos (odds ratio 0,55; IC95% 0,31-0,95). CONCLUSÃO: A incidência de náuseas foi maior do que a de vômitos, e na fase tardia os efeitos adversos foram mais frequentes. Os resultados sugerem que os fatores de risco para náuseas e vômitos induzidos por quimioterapia são o tabaco, a idade (adultos jovens) e o alto potencial emético do quimioterápico.


Subject(s)
Humans , Male , Female , Adult , Aged , Aged, 80 and over , Vomiting/chemically induced , Nausea/chemically induced , Neoplasms/drug therapy , Antineoplastic Agents/adverse effects , Vomiting/drug therapy , Vomiting/epidemiology , Brazil/epidemiology , Incidence , Prospective Studies , Risk Factors , Cohort Studies , Middle Aged , Antiemetics/therapeutic use , Nausea/drug therapy , Nausea/epidemiology , Antineoplastic Agents/therapeutic use
11.
Clinics ; 75: e2209, 2020. tab
Article in English | LILACS | ID: biblio-1133484

ABSTRACT

OBJECTIVES: To assess the outcomes of pediatric patients with laboratory-confirmed coronavirus disease (COVID-19) with or without multisystem inflammatory syndrome in children (MIS-C). METHODS: This cross-sectional study included 471 samples collected from 371 patients (age<18 years) suspected of having severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The study group comprised 66/371 (18%) laboratory-confirmed pediatric COVID-19 patients: 61 (92.5%) patients tested positive on real-time reverse transcription-polymerase chain reaction tests for SARS-CoV-2, and 5 (7.5%) patients tested positive on serological tests. MIS-C was diagnosed according to the criteria of the Center for Disease Control. RESULTS: MIS-C was diagnosed in 6/66 (9%) patients. The frequencies of diarrhea, vomiting, and/or abdominal pain (67% vs. 22%, p=0.034); pediatric SARS (67% vs. 13%, p=0.008); hypoxemia (83% vs. 23%, p=0.006); and arterial hypotension (50% vs. 3%, p=0.004) were significantly higher in patients with MIS-C than in those without MIS-C. The frequencies of C-reactive protein levels >50 mg/L (83% vs. 25%, p=0.008) and D-dimer levels >1000 ng/mL (100% vs. 40%, p=0.007) and the median D-dimer, troponin T, and ferritin levels (p<0.05) were significantly higher in patients with MIS-C. The frequencies of pediatric intensive care unit admission (100% vs. 60%, p=0.003), mechanical ventilation (83% vs. 7%, p<0.001), vasoactive agent use (83% vs. 3%, p<0.001), shock (83% vs. 5%, p<0.001), cardiac abnormalities (100% vs. 2%, p<0.001), and death (67% vs. 3%, p<0.001) were also significantly higher in patients with MIS-C. Similarly, the frequencies of oxygen therapy (100% vs. 33%, p=0.003), intravenous immunoglobulin therapy (67% vs. 2%, p<0.001), aspirin therapy (50% vs. 0%, p<0.001), and current acute renal replacement therapy (50% vs. 2%, p=0.002) were also significantly higher in patients with MIS-C. Logistic regression analysis showed that the presence of MIS-C was significantly associated with gastrointestinal manifestations [odds ratio (OR)=10.98; 95%CI (95% confidence interval)=1.20-100.86; p=0.034] and hypoxemia [OR=16.85; 95%CI=1.34-211.80; p=0.029]. Further univariate analysis showed a positive association between MIS-C and death [OR=58.00; 95%CI=6.39-526.79; p<0.0001]. CONCLUSIONS: Pediatric patients with laboratory-confirmed COVID-19 with MIS-C had a severe clinical spectrum with a high mortality rate. Our study emphasizes the importance of investigating MIS-C in pediatric patients with COVID-19 presenting with gastrointestinal involvement and hypoxemia.


Subject(s)
Humans , Male , Child , Pneumonia, Viral/complications , Pneumonia, Viral/mortality , Coronavirus Infections/complications , Coronavirus Infections/mortality , Coronavirus , Pandemics , Respiration, Artificial , Vomiting/etiology , Abdominal Pain/etiology , Cross-Sectional Studies , Immunoglobulins, Intravenous/therapeutic use , Coronavirus Infections/diagnosis , Coronavirus Infections/therapy , Systemic Inflammatory Response Syndrome/epidemiology , Diarrhea/etiology , Fever/etiology , Betacoronavirus , SARS-CoV-2 , COVID-19 , Glucocorticoids/therapeutic use , Mucocutaneous Lymph Node Syndrome/therapy , Mucocutaneous Lymph Node Syndrome/epidemiology , Mucocutaneous Lymph Node Syndrome/virology
12.
Evid. actual. práct. ambul ; 23(4): e002076, 2020. tab
Article in Spanish | LILACS | ID: biblio-1141348

ABSTRACT

Sobre la base de una viñeta clínica de un niño con gastroenteritis aguda sin deshidratación, el autor de este artículo realiza una búsqueda bibliográfica para revisar la evidencia que avala el uso de ondansetrón para tratar sus vómitos, práctica bastante común en instituciones con acceso a este fármaco en sus centrales de emergencia. Luego de dicha búsqueda, el autor concluye que en niños con gastroenteritis aguda sin deshidratación, la administración de ondansetrón no reduce la necesidad de hidratación intravenosa ni la frecuencia ni la severidad de los vómitos. (AU)


Based on a clinical vignette of a child with acute gastroenteritis without dehydration, the author of this article performs a literature search to review the evidence supporting the use of ondansetron to treat his vomiting, a fairly common practice in institutions with access to this drug in their emergency rooms. After this search, the author concludes that in children with acute gastroenteritis without dehydration, the administration of ondansetron does not reduce the need for intravenous hydration or the frequency or severity of vomiting. (AU)


Subject(s)
Humans , Male , Child, Preschool , Ondansetron/therapeutic use , Gastroenteritis/drug therapy , Vomiting/prevention & control , Vomiting/drug therapy , Randomized Controlled Trials as Topic , Ondansetron/administration & dosage , Dehydration/prevention & control , Dehydration/therapy , Diarrhea , Fluid Therapy/methods , Gastroenteritis/diagnosis , Gastroenteritis/diet therapy
13.
Einstein (Säo Paulo) ; 18: eRC4641, 2020. graf
Article in English | LILACS | ID: biblio-1142873

ABSTRACT

ABSTRACT Vomiting episodes in newborns are extremely common and often attributed to gastroesophageal reflux. The symptoms of vomiting, however, may be caused by other complications. In this report, we present two cases of a 1-month-old male and a 2-month-old female, both presenting vomiting episodes that led to malnutrition. Some pediatricians often attribute the diagnosis of gastroesophageal reflux to newborns that are vomiting; however, there is a portion of the population that has other causes that lead to similar symptoms. The pediatrician should be alert to the clinical signs of weight loss, dehydration and malnutrition to investigate other causes of vomiting.


RESUMO Episódios de vômito em recém-nascidos são extremamente comuns e frequentemente atribuídos a refluxo gastresofágico. Os sintomas de vômito, no entanto, podem ser causados por outras complicações. Neste relato, apresentamos dois casos: um lactente masculino, com 1 mês de idade, e um feminino, com 2 meses, ambos apresentando episódios de vômitos que levaram à desnutrição. Alguns pediatras costumam atribuir o diagnóstico de refluxo gastresofágico a recém-nascidos que estão vomitando; mas parcela da população tem outras causas que levam a sintomas semelhantes. O pediatra deve estar atento aos sinais clínicos de perda de peso, desidratação e desnutrição, para investigar outras causas de vômitos.


Subject(s)
Humans , Male , Female , Vomiting/etiology , Gastroesophageal Reflux/diagnostic imaging , Duodenum/diagnostic imaging , Ultrasonography , Diagnosis, Differential , Esophagus/diagnostic imaging
14.
Rev Rene (Online) ; 21: e43243, 2020. tab
Article in Portuguese | LILACS, BDENF | ID: biblio-1101377

ABSTRACT

RESUMO Objetivo analisar os fatores associados ao desenvolvimento de agravos gastrointestinais, no primeiro ano de vida de prematuros tardios e moderados. Métodos estudo longitudinal, que acompanhou lactentes nascidos tardios e moderados, durante o primeiro ano de vida, via telefone, para desenvolvimento de agravos gastrointestinais, na percepção materna. Dados coletados por meio de escala likert, na avaliação da condição aguda, e analisados sob comparação de frequência e odds ratio (p<5% e Intervalo de Confiança 95%) entre as variáveis. Resultados os agravos gastrointestinais mais frequentes na avaliação dos primeiros meses de vida foram a cólica e o vômito, que reduziram a intensidade, quanto mais perto do primeiro ano de vida do lactente, seguidos do agravo diarreia que manteve intensidade constante ao longo do primeiro ano. Conclusão o estudo traz implicação para identificação dos fatores de risco, tendo em vista a vulnerabilidade da população de prematuros, ainda pouco descrita na literatura.


ABSTRACT Objective to analyze the factors associated with the development of gastrointestinal disorders in the first year of life of late and moderate premature infants. Methods longitudinal study, which followed infants born late and moderate, during the first year of life, via telephone, to develop gastrointestinal disorders, in the maternal perception. Data collected using the Likert scale, in the assessment of acute condition, and analyzed under comparison of frequency and odds ratios (p<5% and 95% Confidence Interval) between variables. Results the most frequent gastrointestinal injuries in the assessment of the first months of life were colic and vomiting, which reduced the intensity, the closer to the infant's first year of life, followed by the diarrheal condition that maintained constant intensity throughout the first year. Conclusion the study has implications for the identification of risk factors, in view of the vulnerability of the premature population, still little described in the literature.


Subject(s)
Vomiting , Colic , Risk Factors , Diarrhea , Infant, Premature, Diseases
16.
Ciênc. cuid. saúde ; 19: e46652, 20200000.
Article in Portuguese | LILACS, BDENF | ID: biblio-1122057

ABSTRACT

Objectives: to identify the knowledge of oncological patients undergoing outpatient chemotherapy regarding emergency signs and symptoms.Methods: It is a descriptive, qualitative study. Two instruments were used: a questionnaire to characterize the participants and an open interview. The analysis of the first instrument was based on simple descriptive statistics; the second by thematic analysis. Results: The symptoms described by the participants were: fever, nausea, vomiting, constipation, inability/difficulty with food intake, headache, generalized pain or pain in places that refer to the tumor, dyspnea, vertigo, loss of consciousness, loss of ability to walk, chest pain and sudden changes in systemic pressure level (increase or decrease). As conditions that can interfere with the decision to seek emergency services, the manifestation of abnormal symptoms for the patient, the patient's knowledge about the pathology and treatment, as well as the patient's previous experience with the emergency service was identified.Conclusion: In short, the reasons that lead cancer patients to seek emergency are linked to the "severity" that it attributes to the effects of treatment.


Objetivo: identificar o conhecimento de pacientes oncológicos em tratamento quimioterápico ambulatorial sobre os sinais e sintomas de emergência. Métodos: Estudo descritivo, qualitativo. Utilizaram-se dois instrumentos: um questionário de caracterização dos participantes e uma entrevista aberta. A análise do primeiro instrumento foi por estatística descritiva simples; o segundo por análise temática. Resultados: Os sintomas descritos pelos participantes foram: febre, náuseas, vômitos, constipação, incapacidade/dificuldade de ingestão alimentar, cefaleia, dor generalizada ou dor nos locais que remetem ao tumor, dispneia, vertigem, perda de consciência, perda da capacidade de andar, dor no peito e variações bruscas de nível de pressão sistêmica (aumento ou diminuição).Como condições que podem interferir na decisão da busca pelo serviço de emergência, foi identificada a manifestação de sintomas anormais para o paciente, o conhecimento do paciente sobre a patologia e tratamento, além da experiência prévia do paciente com o serviço de emergência. Conclusão: Em suma, os motivos que levam o paciente oncológico a buscar a emergência estão ligados à "gravidade" que o mesmo atribui aos efeitos do tratamento.


Subject(s)
Humans , Male , Female , Signs and Symptoms , Drug Therapy , Emergencies , Patients , Vomiting , Constipation , Eating , Fever , Headache , Medical Oncology , Nausea , Neoplasms
17.
Article in Korean | WPRIM | ID: wpr-811440

ABSTRACT

A 64-year-old man was treated with sunitinib as a first-line therapy for metastatic renal cell carcinoma. He was given oral sunitinib in cycles of 50 mg once daily for 2 weeks followed by a week off. During the 5th week of treatment right upper quadrant pain developed, but this resolved spontaneously during the 6th week (off treatment). However, on the 8th week of treatment, he was admitted to hospital because the acute right upper quadrant pain recurred with nausea, vomiting, and fever. Acute acalculous cholecystitis was then diagnosed by ultrasonography and CT. In addition, his laboratory findings indicated disseminated intravascular coagulation. Accordingly, sunitinib therapy was discontinued and broad-spectrum antibiotics initiated. He subsequently recovered after emergent percutaneous cholecystostomy. His Naranjo Adverse Drug Reaction Probability Scale score was 7, indicaing a probable association of the event with sunitinib. Suspicion of sunitinib-related acute cholecystitis is required, because, although uncommon, it can be life-threatening.


Subject(s)
Acalculous Cholecystitis , Anti-Bacterial Agents , Carcinoma, Renal Cell , Cholecystitis, Acute , Cholecystostomy , Disseminated Intravascular Coagulation , Drug-Related Side Effects and Adverse Reactions , Fever , Humans , Middle Aged , Nausea , Ultrasonography , Vomiting
18.
Article in Korean | WPRIM | ID: wpr-811332

ABSTRACT

PURPOSE: To report the clinical manifestations and computed tomography (CT) findings of patients with a trapdoor type medial orbital wall blowout fracture.METHODS: From March 2009 to October 2016, the clinical records and computed tomography findings of patients who underwent surgical treatment for a trapdoor type medial orbital wall blowout fracture were retrospectively analyzed.RESULTS: A total of eight patients (six males and two females) were enrolled with a combined mean age of 14.4 years. Clinical manifestations were eyeball movement limitation (abduction and adduction) and ocular motility pain (eight patients, 100%), diplopia (seven patients, 87.5%), and nausea and vomiting (four patients, 50%). On CT, the distance from the orbital apex to the fracture site was an average of 22.0 mm and occurred in the middle position of the entire wall. Two patients had missed rectus completely dislocated into the ethmoid sinus through the fracture gap and six patients had definite involvement in the fracture gap and edema of the medial rectus muscle. The medial rectus muscle cross-sectional area was 47.7 mm² which was edematous compared to the contralateral eye (40.1 mm²). Orbital wall reconstruction was performed an average of 4.1 days after the injury. In all patients with oculocardiac reflex-like nausea and vomiting immediately improved after surgery. Six out of eight patients who had eyeball movement limitations (abduction and adduction) preoperatively showed adduction limitation after surgery. The eyeball movement limitation and diplopia disappeared 11.7 days and 46.7 days after surgery, respectively.CONCLUSIONS: Patients with trapdoor type medial wall blowout fracture showed characteristic computed tomographic findings and clinical manifestations such as eyeball movement limitation, ocular motility pain, diplopia, and oculocardiac reflex. An understanding of clinical findings and quick surgical treatment are therefore required. The type of eyeball movement limitation was abduction and adduction limitation preoperatively and adduction limitation postoperatively.


Subject(s)
Diplopia , Edema , Ethmoid Sinus , Humans , Male , Nausea , Orbit , Reflex, Oculocardiac , Retrospective Studies , Vomiting
19.
Article in Korean | WPRIM | ID: wpr-811299

ABSTRACT

Many hospitals have patients perform preparative fasting prior to contrast-enhanced computed tomography to prevent nausea, vomiting, and accompanying aspiration pneumonia. This policy has been regarded as reasonable because there are many side effects such as vomiting when ionic high-osmolar contrast media are used. Recent advancements in contrast media development, side effects such as nausea and vomiting have markedly decreased. However, fasting prior to the contrast-enhanced computed tomography examination is still customary. While debatable, it is not clear that fasting prior to the use of contrast media has a beneficial effect on the prevention of vomiting. On the contrary, excessive fasting can cause patient dissatisfaction, dehydration, and exhaustion. Therefore, before using contrast media, the duration of fasting should be determined based on consideration of the risks, benefits, and patient’s comfort. In particular, to prevent dehydration, limitation of liquid intake during fasting is not recommended.


Subject(s)
Contrast Media , Dehydration , Fasting , Humans , Nausea , Pneumonia, Aspiration , Vomiting
SELECTION OF CITATIONS
SEARCH DETAIL